Open Access

[Retracted] MicroRNA‑126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial‑to‑mesenchymal transition and ERK/MAPK signaling pathway

  • Authors:
    • Yuhua Zhang
    • Xiaobo Qin
    • Juan Jiang
    • Wenjie Zhao
  • View Affiliations

  • Published online on: July 1, 2024     https://doi.org/10.3892/ol.2024.14548
  • Article Number: 415
  • Copyright : © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Lett 20: [Related article:] 1327-1335, 2020; DOI: 10.3892/ol.2020.11687

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell migration and invasion assay data shown in Fig. 2B and D on p. 1332 had already appeared in previously published articles written by different authors at different research institutes, one of which has been retracted. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Letters, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

September-2024
Volume 28 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, Qin X, Jiang J and Zhao W: [Retracted] MicroRNA‑126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial‑to‑mesenchymal transition and ERK/MAPK signaling pathway. Oncol Lett 28: 415, 2024.
APA
Zhang, Y., Qin, X., Jiang, J., & Zhao, W. (2024). [Retracted] MicroRNA‑126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial‑to‑mesenchymal transition and ERK/MAPK signaling pathway. Oncology Letters, 28, 415. https://doi.org/10.3892/ol.2024.14548
MLA
Zhang, Y., Qin, X., Jiang, J., Zhao, W."[Retracted] MicroRNA‑126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial‑to‑mesenchymal transition and ERK/MAPK signaling pathway". Oncology Letters 28.3 (2024): 415.
Chicago
Zhang, Y., Qin, X., Jiang, J., Zhao, W."[Retracted] MicroRNA‑126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial‑to‑mesenchymal transition and ERK/MAPK signaling pathway". Oncology Letters 28, no. 3 (2024): 415. https://doi.org/10.3892/ol.2024.14548